Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 1/20 | 0.42 |
| ▸ | HTR2C | P28335 | 1/20 | 0.42 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.42 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.42 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.42 |
| ▸ | KCNN4 | O15554 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.41 |
| ▸ | PDK1 | Q15118 | 4/20 | 0.40 |
| ▸ | PDK2 | Q15119 | 4/20 | 0.40 |
| ▸ | PDK3 | Q15120 | 4/20 | 0.40 |
| ▸ | PDK4 | Q16654 | 4/20 | 0.40 |
| ▸ | CES2 | O00748 | 1/20 | 0.39 |
| ▸ | CES1 | P23141 | 1/20 | 0.39 |
| ▸ | KIF11 | P52732 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24542 | 1.00 | HTR2A (0.42) | HTR2AHTR2CADRA1AOPRK1KCNH2 | |
| SCHEMBL30501925 | 0.82 | KCNN4 (0.44) | HTR2AHTR2CADRA1AOPRK1KCNH2 | |
| SCHEMBL785777 | 0.82 | KCNN4 (0.44) | HTR2AHTR2CADRA1AOPRK1KCNH2 | |
| SCHEMBL1417552 | 0.80 | KCNN4 (0.42) | HTR2AHTR2CADRA1AOPRK1KCNH2 | |
| SCHEMBL1417550 | 0.80 | KCNN4 (0.42) | HTR2AHTR2CADRA1AOPRK1KCNH2 | |
| SCHEMBL4838145 | 0.80 | KCNN4 (0.42) | HTR2AHTR2CADRA1AOPRK1KCNH2 | |
| SCHEMBL31612950 | 0.79 | LMNA (0.47) | KCNN4ALDH1A1L3MBTL1PDK1PDK2 | |
| SCHEMBL31612951 | 0.79 | LMNA (0.47) | KCNN4ALDH1A1L3MBTL1PDK1PDK2 | |
| SCHEMBL4564870 | 0.79 | KCNN4 (0.45) | HTR2AHTR2CADRA1AOPRK1KCNH2 | |
| SCHEMBL2798675 | 0.79 | CYP2C9 (0.50) | HTR2AHTR2CADRA1AOPRK1KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 64 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2970112-B1 | PHENYL CARBAMATE COMPOUND AND A COMPOSITION FOR PREVENTING OR TREATING A MEMORY LOSS-RELATED DISEASE COMPRISING THE SAME | BIO PHARM SOLUTIONS CO LTD (KR) | 2025-03-12 | — | — | EP | disclosed |
| EP-2968210-B1 | PHENYL CARBAMATE COMPOUNDS FOR USE IN PREVENTING OR TREATING PEDIATRIC EPILESY | BIO PHARM SOLUTIONS CO LTD (KR) | 2024-09-11 | — | — | EP | disclosed |
| US-11931332-B2 | Phenyl alkyl carbamate compounds for use in preventing or treating neurodegenerative disease | BIO-PHARM SOLUTIONS CO., LTD. (KR) | 2024-03-19 | — | — | US | disclosed |
| EP-4204395-A1 | PHENYL ALKYL CARBAMATE COMPOUNDS FOR USE IN PREVENTING OR TREATING NEURODEGENERATIVE DISEASE | Bio-Pharm Solutions Co., Ltd. (KR) | 2023-07-05 | — | — | EP | disclosed |
| CN-109939092-B | Phenyl carbamate compounds for use in preventing or treating pediatric epilepsy and epilepsy-related syndrome | 比皮艾思药物研发有限公司 | 2022-03-22 | — | — | CN | disclosed |
| US-10525030-B2 | Phenyl carbamate compound and a composition for neuroprotection comprising the same | BIO-PHARM SOLUTIONS CO., LTD. (KR) | 2020-01-07 | — | — | US | disclosed |
| CN-105164103-B | Phenyl carbamate compounds and composition for preventing or treating memory loss-related diseases containing the same | 比皮艾思药物研发有限公司 | 2019-12-06 | — | — | CN | disclosed |
| EP-2613783-B1 | METHODS FOR THE TREATMENT OR PROPHYLAXIS OF THROMBOSIS OR EMBOLISM | IPCA LABORATORIES LTD (IN) | 2019-06-12 | — | — | EP | disclosed |
| US-10105353-B2 | Anti-thrombotic compounds | IPCA LABORATORIES LIMITED (IN) | 2018-10-23 | — | — | US | disclosed |
| US-9956197-B2 | Phenyl carbamate compounds for use in preventing or treating pediatric epilepsy and epilepsy-related syndromes | BIO-PHARM SOLUTIONS CO., LTD. (KR) | 2018-05-01 | — | — | US | disclosed |
| US-20130165410-A1 | PHENYL CARBAMATE COMPOUNDS FOR USE IN PREVENTING OR TREATING STROKE | BIO-PHARM SOLUTIONS CO., LTD. (KR) | 2013-06-27 | — | — | US | disclosed |
| US-20130165408-A1 | PHENYL CARBAMATE COMPOUNDS FOR USE IN PREVENTING OR TREATING EPILESY | BIO-PHARM SOLUTIONS CO., LTD. (KR) | 2013-06-27 | — | — | US | disclosed |
| US-20130005801-A1 | PHENYLCARBAMATE COMPOUND AND MUSCLE RELAXANT CONTAINING THE SAME | BIO-PHARM SOLUTIONS CO., LTD. (KR) | 2013-01-03 | — | — | US | disclosed |
| WO-2013001544-A1 | ANTI-THROMBOTIC COMPOUNDS | IPCA LABORATORIES LIMITED (IN) | 2013-01-03 | — | — | WO | disclosed |
| EP-2540729-A1 | (7aS, 2'S)-2-Oxoclopidogrel as anti-thrombotic compound | IPCA Laboratories Limited (IN) | 2013-01-02 | — | — | EP | disclosed |
| US-20120329762-A1 | ANTI-THROMBOTIC COMPOUNDS | IPCA LABORATORIES LIMITED (IN) | 2012-12-27 | — | — | US | disclosed |
| US-20120329763-A1 | ANTI-THROMBOTIC COMPOUNDS | IPCA LABORATORIES LIMITED (IN) | 2012-12-27 | — | — | US | disclosed |
| US-20120184762-A1 | PROCESS FOR PREPARATION OF PHENYL CARBAMATE DERIVATIVES | BIO-PHARM SOLUTIONS CO., LTD. (KR) | 2012-07-19 | — | — | US | disclosed |
| US-20120053157-A1 | METHODS FOR THE TREATMENT OR PROPHYLAXIS OF THROMBOSIS OR EMBOLISM | IPCA LABORATORIES LIMITED (IN) | 2012-03-01 | — | — | US | disclosed |
| WO-2012025942-A1 | METHODS FOR THE TREATMENT OR PROPHYLAXIS OF THROMBOSIS OR EMBOLISM | IPCA LABORATORIES LIMITED (IN) | 2012-03-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120329763-A1 | ANTI-THROMBOTIC COMPOUNDS | TBXA2R, SERPINC1, F2 | HTR2A 652/4885HTR2C 273/4885ADRA1A 451/4885 |
| US-20130165408-A1 | PHENYL CARBAMATE COMPOUNDS FOR USE IN PREVENTING OR TREATING EPILESY | CHAT, BCHE, GABBR1 | HTR2A 2103/4885HTR2C 2115/4885ADRA1A 3765/4885 |
| US-10105353-B2 | Anti-thrombotic compounds | TBXA2R, SERPINC1, F2 | HTR2A 652/4885HTR2C 273/4885ADRA1A 451/4885 |
| US-20120053157-A1 | METHODS FOR THE TREATMENT OR PROPHYLAXIS OF THROMBOSIS OR EMBOLISM | F2, PLAT, SELP | HTR2A 1845/4885HTR2C 1936/4885ADRA1A 1448/4885 |
| US-20130005801-A1 | PHENYLCARBAMATE COMPOUND AND MUSCLE RELAXANT CONTAINING THE SAME | CPT1B, MYLK, PYGM | HTR2A 2334/4885HTR2C 1798/4885ADRA1A 513/4885 |
| US-10525030-B2 | Phenyl carbamate compound and a composition for neuroprotection comprising the same | CHAT, BAX, CASP3 | HTR2A 1347/4885HTR2C 2755/4885ADRA1A 3440/4885 |
| US-11931332-B2 | Phenyl alkyl carbamate compounds for use in preventing or treating neurodegenerative disease | SNCA, MAPT, CHAT | HTR2A 3487/4885HTR2C 4283/4885ADRA1A 1348/4885 |
| US-20130165410-A1 | PHENYL CARBAMATE COMPOUNDS FOR USE IN PREVENTING OR TREATING STROKE | CPS1, PROC, DPP7 | HTR2A 3371/4885HTR2C 3341/4885ADRA1A 4254/4885 |
| US-20120184762-A1 | PROCESS FOR PREPARATION OF PHENYL CARBAMATE DERIVATIVES | CPS1, BCHE, ACHE | HTR2A 1462/4885HTR2C 1378/4885ADRA1A 3782/4885 |
| US-20120329762-A1 | ANTI-THROMBOTIC COMPOUNDS | TBXA2R, SERPINC1, F2 | HTR2A 652/4885HTR2C 273/4885ADRA1A 451/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.